
CAS 667880-38-8
:5-({1-[2-(2,4-dimethylphenoxy)ethyl]-2-methyl-1H-indol-3-yl}methyliden)-2-thioxodihydropyrimidin-4,6(1H,5H)-dion
- IAC-8
- 5-({1-[2-(2,4-dimethylphenoxy)ethyl]-2-methyl-1H-indol-3-yl}methylene)-2-thioxodihydropyrimidine-4,6(1H,5H)-dione
ZLDI-8
CAS:ZLDI-8 is an inhibitor of Notch activating/cleaving enzyme ADAM-17 and inhibits the cleavage of Notch protein.
Formel:C24H23N3O3SReinheit:98.09%Farbe und Form:SolidMolekulargewicht:433.52ZLDI-8
CAS:ZLDI-8 is a prognostic marker that can be used to predict the response of a patient with non-small-cell lung cancer to chemotherapy. The assay detects the presence of ZLDI-8 protein in cell culture, and can be used to predict the response of a patient with non-small-cell lung cancer to chemotherapy. The level of ZLDI-8 protein in cells is not affected by etoposide treatment, indicating that it is not an oncogene. ZLDI-8 expression is correlated with tumor progression and has been shown to be involved in epithelial mesenchymal transition (EMT). This protein also has potential as an antitumor agent due to its ability to inhibit tumor growth and induce apoptosis through inhibition of angiogenesis, proliferation, and invasion.
Formel:C24H23N3O3SReinheit:Min. 95%Molekulargewicht:433.5 g/mol



